MYNOVOCURE Trademark

Trademark Overview


On Friday, November 18, 2022, a trademark application was filed for MYNOVOCURE with the United States Patent and Trademark Office. The USPTO has given the MYNOVOCURE trademark a serial number of 97683297. The federal status of this trademark filing is REGISTERED as of Tuesday, June 11, 2024. This trademark is owned by Novocure GmbH. The MYNOVOCURE trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, and Education & Entertainment Services categories with the following description:

Medical educational services, namely, providing individualized and group instruction in the nature of training, classes, seminars and conferences for patients requiring treatment of solid tumor cancers and caregivers of patients requiring treatment of solid tumor cancers in the field of therapies and patient support for cancer treatment; educational services, providing of training and education, namely, providing information to caregivers in the areas of patient support services and information about therapies for cancer treatment, all of the aforesaid provided via telephone, e-learning and personal training sessions, and non-downloadable webinars and printed material distributed in connection therewith

Providing information about the financial administration of patient reimbursement programs designed to assist patients requiring treatment of solid tumor cancers regarding medical treatment payment plan options; providing patient support services, namely, providing insurance information to help patients requiring treatment of solid tumor cancers to understand their insurance and plan benefits and providing insurance reimbursement assistance to eligible patients

Providing information about the business administration of patient reimbursement programs designed to assist patients requiring treatment of solid tumor cancers regarding medical treatment payment plan options; providing business administration assistance to patients requiring treatment of solid tumor cancers regarding treatment payment plan options, namely, administration of patient reimbursement programs for patients requiring treatment of solid tumor cancers
mynovocure

General Information


Serial Number97683297
Word MarkMYNOVOCURE
Filing DateFriday, November 18, 2022
Status700 - REGISTERED
Status DateTuesday, June 11, 2024
Registration Number7415304
Registration DateTuesday, June 11, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 25, 2023

Trademark Statements


Goods and ServicesMedical educational services, namely, providing individualized and group instruction in the nature of training, classes, seminars and conferences for patients requiring treatment of solid tumor cancers and caregivers of patients requiring treatment of solid tumor cancers in the field of therapies and patient support for cancer treatment; educational services, providing of training and education, namely, providing information to caregivers in the areas of patient support services and information about therapies for cancer treatment, all of the aforesaid provided via telephone, e-learning and personal training sessions, and non-downloadable webinars and printed material distributed in connection therewith
Pseudo MarkMY NOVO CURE
Goods and ServicesProviding information about the financial administration of patient reimbursement programs designed to assist patients requiring treatment of solid tumor cancers regarding medical treatment payment plan options; providing patient support services, namely, providing insurance information to help patients requiring treatment of solid tumor cancers to understand their insurance and plan benefits and providing insurance reimbursement assistance to eligible patients
Goods and ServicesProviding information about the business administration of patient reimbursement programs designed to assist patients requiring treatment of solid tumor cancers regarding medical treatment payment plan options; providing business administration assistance to patients requiring treatment of solid tumor cancers regarding treatment payment plan options, namely, administration of patient reimbursement programs for patients requiring treatment of solid tumor cancers

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, December 9, 2022
Primary Code035
First Use Anywhere DateFriday, November 21, 2031
First Use In Commerce DateTuesday, November 21, 2023

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, December 9, 2022
Primary Code036
First Use Anywhere DateTuesday, November 21, 2023
First Use In Commerce DateTuesday, November 21, 2023

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateFriday, December 9, 2022
Primary Code041
First Use Anywhere DateTuesday, November 21, 2023
First Use In Commerce DateTuesday, November 21, 2023

Trademark Owner History


Party NameNovocure GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressRoot D4 6039
CH

Party NameNovocure GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressRoot D4 6039
CH

Party NameNovocure GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRoot D4 6039
CH

Trademark Events


Event DateEvent Description
Tuesday, November 22, 2022NEW APPLICATION ENTERED
Friday, December 9, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 30, 2023ASSIGNED TO EXAMINER
Tuesday, June 13, 2023NON-FINAL ACTION WRITTEN
Tuesday, June 13, 2023NON-FINAL ACTION E-MAILED
Tuesday, June 13, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 15, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 15, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 16, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 20, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 25, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, July 5, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 25, 2023PUBLISHED FOR OPPOSITION
Tuesday, September 19, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, February 26, 2024USE AMENDMENT FILED
Tuesday, March 19, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 26, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, March 19, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, May 6, 2024NON-FINAL ACTION E-MAILED
Tuesday, May 7, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, May 6, 2024SU - NON-FINAL ACTION - WRITTEN
Monday, May 6, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 7, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, May 8, 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, June 11, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, June 11, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED